OraSure Technologies, Inc.

OSUR ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-68.7M $-19.5M $53.7M $-17.1M $-23.0M $-14.9M $16.7M $20.4M
Depreciation & Amortization $10.2M $10.9M $20.9M $15.3M $11.7M $9.4M $7.3M $6.5M
Depreciation $9.9M $9.8M $17.9M $11.7M $7.5M $5.5M $4.4M $3.8M
Amortization $300.0K $700.0K $2.0M $2.3M $3.3M $3.2M $2.5M $2.6M
Stock-Based Compensation $10.1M $11.9M $10.7M $11.6M $7.8M $7.1M $4.1M $15.2M
Net Cash from Operating Activities $-49.0M $27.4M $141.6M $-47.2M $-35.4M $5.8M $9.8M $39.1M
Investing Activities
Capital Expenditures $4.2M $3.8M $5.8M $6.8M $21.9M $26.7M $9.3M $6.3M
Business Acquisitions $3.6M $5.0M $0 $0 — $3.0M $23.8M —
Net Cash from Investing Activities $-6.8M $-39.0M $66.2M $21.1M $-5.5M $-14.0M $-19.8M $-17.4M
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases $15.0M $0 $0 $2.3M $2.1M $2.1M $3.7M $3.6M
Net Cash from Financing Activities $-16.9M $-4.2M $-3.0M $-3.8M $-2.8M $92.5M $-4.7M $-1.9M
Net Change in Cash $-68.5M $-22.6M $206.4M $-32.8M $-44.0M $85.1M $-12.7M $15.6M
Free Cash Flow $-53.2M $23.6M $135.8M $-54.0M $-57.3M $-20.9M $490.0K $32.7M
← Newer Page 1 of 3 Older →